Complex DDI by Fenebrutinib and the Use of Transporter Endogenous Biomarkers to Elucidate the Mechanism of DDI.
Clin Pharmacol Ther
; 107(1): 269-277, 2020 01.
Article
in En
| MEDLINE
| ID: mdl-31376152
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Piperazines
/
Pyridones
/
Protein Kinase Inhibitors
/
Cytochrome P-450 CYP3A
/
ATP Binding Cassette Transporter, Subfamily G, Member 2
/
Neoplasm Proteins
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Clin Pharmacol Ther
Year:
2020
Type:
Article
Affiliation country:
United States